Papadopoulou A - Search Results

1

Association of clinical headache features with stroke location: An MRI voxel-based symptom lesion mapping study.

Seifert CL, Schönbach EM, Zimmer C, Förschler A, Tölle TR, Feurer R, Gempt J, Papadopoulou A, Magon S, Sprenger T, Poppert H. Seifert CL, et al. Among authors: papadopoulou a. Cephalalgia. 2018 Feb;38(2):283-291. doi: 10.1177/0333102416686342. Epub 2016 Dec 22. Cephalalgia. 2018. PMID: 28006971

2

Teriflunomide for oral therapy in multiple sclerosis.

Papadopoulou A, Kappos L, Sprenger T. Papadopoulou A, et al. Expert Rev Clin Pharmacol. 2012 Nov;5(6):617-28. doi: 10.1586/ecp.12.56. Expert Rev Clin Pharmacol. 2012. PMID: 23234322

3

Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.

Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK. Papadopoulou A, et al. Mult Scler. 2013 Sep;19(10):1290-6. doi: 10.1177/1352458513475490. Epub 2013 Mar 4. Mult Scler. 2013. PMID: 23459568

4

Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.

Papadopoulou A, Menegola M, Kuhle J, Ramagopalan SV, D'Souza M, Sprenger T, Radue EW, Kappos L, Yaldizli Ö. Papadopoulou A, et al. Mult Scler. 2014 Mar;20(3):322-30. doi: 10.1177/1352458513495583. Epub 2013 Jul 11. Mult Scler. 2014. PMID: 23846352 Clinical Trial.

5

The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.

Yaldizli Ö, Penner IK, Frontzek K, Naegelin Y, Amann M, Papadopoulou A, Sprenger T, Kuhle J, Calabrese P, Radü EW, Kappos L, Gass A. Yaldizli Ö, et al. Among authors: papadopoulou a. Mult Scler. 2014 Mar;20(3):356-64. doi: 10.1177/1352458513496880. Epub 2013 Aug 19. Mult Scler. 2014. PMID: 23959709

6

Detection of cerebrospinal fluid leaks by intrathecal contrast-enhanced magnetic resonance myelography.

Papadopoulou A, Ahlhelm FJ, Ulmer S, Kappos L, Sprenger T. Papadopoulou A, et al. JAMA Neurol. 2013 Dec;70(12):1576-7. doi: 10.1001/jamaneurol.2013.744. JAMA Neurol. 2013. PMID: 24166493 No abstract available.

7

Intrathecal gadolinium for magnetic resonance myelography in spontaneous intracranial hypotension: valuable but may be risky--reply.

Papadopoulou A, Ahlhelm FJ, Sprenger T. Papadopoulou A, et al. JAMA Neurol. 2014 Jun;71(6):802-3. doi: 10.1001/jamaneurol.2014.577. JAMA Neurol. 2014. PMID: 24911131 No abstract available.

8

Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis.

Papadopoulou A, Kappos L, Sprenger T. Papadopoulou A, et al. Expert Opin Drug Saf. 2015 May;14(5):749-59. doi: 10.1517/14740338.2015.1014795. Epub 2015 Feb 17. Expert Opin Drug Saf. 2015. PMID: 25687236 Review.

9

MRI characteristics of periaqueductal lesions in multiple sclerosis.

Papadopoulou A, Naegelin Y, Weier K, Amann M, Hirsch J, von Felten S, Yaldizli O, Sprenger T, Radue EW, Kappos L, Gass A. Papadopoulou A, et al. Mult Scler Relat Disord. 2014 Jul;3(4):542-51. doi: 10.1016/j.msard.2014.01.001. Epub 2014 Jan 18. Mult Scler Relat Disord. 2014. PMID: 25877067

10

Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis.

Amann M, Papadopoulou A, Andelova M, Magon S, Mueller-Lenke N, Naegelin Y, Stippich C, Radue EW, Bieri O, Kappos L, Sprenger T. Amann M, et al. Among authors: papadopoulou a. J Neurol. 2015 Aug;262(8):1909-17. doi: 10.1007/s00415-015-7793-5. Epub 2015 Jun 5. J Neurol. 2015. PMID: 26041614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters